Artemis Investment Management LLP Sells 214,836 Shares of Anthem, Inc. (NYSE:ANTM)
Artemis Investment Management LLP reduced its stake in shares of Anthem, Inc. (NYSE:ANTM) by 66.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 108,451 shares of the company’s stock after selling 214,836 shares during the period. Artemis Investment Management LLP’s holdings in Anthem were worth $38,908,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. Ascent Wealth Partners LLC lifted its stake in Anthem by 3.0% during the 1st quarter. Ascent Wealth Partners LLC now owns 963 shares of the company’s stock valued at $346,000 after acquiring an additional 28 shares in the last quarter. Pinnacle Financial Partners Inc. increased its stake in Anthem by 2.0% in the 4th quarter. Pinnacle Financial Partners Inc. now owns 1,740 shares of the company’s stock valued at $515,000 after buying an additional 34 shares during the last quarter. Chicago Capital LLC lifted its position in shares of Anthem by 1.8% during the 4th quarter. Chicago Capital LLC now owns 2,036 shares of the company’s stock worth $654,000 after buying an additional 36 shares in the last quarter. Brandywine Oak Private Wealth LLC grew its holdings in shares of Anthem by 4.0% in the fourth quarter. Brandywine Oak Private Wealth LLC now owns 940 shares of the company’s stock valued at $301,000 after acquiring an additional 36 shares in the last quarter. Finally, Farmers Trust Co. lifted its holdings in Anthem by 2.8% during the first quarter. Farmers Trust Co. now owns 1,313 shares of the company’s stock worth $472,000 after acquiring an additional 36 shares during the period. 89.36% of the stock is owned by institutional investors.
In other Anthem news, Director Ryan M. Schneider acquired 1,700 shares of the business’s stock in a transaction on Thursday, February 4th. The shares were acquired at an average price of $296.03 per share, for a total transaction of $503,251.00. Following the completion of the acquisition, the director now owns 2,921 shares in the company, valued at $864,703.63. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Ronald W. Penczek sold 2,068 shares of the firm’s stock in a transaction that occurred on Friday, March 5th. The shares were sold at an average price of $333.94, for a total value of $690,587.92. Following the transaction, the chief accounting officer now directly owns 3,137 shares of the company’s stock, valued at approximately $1,047,569.78. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by company insiders.
Anthem (NYSE:ANTM) last issued its quarterly earnings results on Tuesday, April 20th. The company reported $7.01 EPS for the quarter, beating analysts’ consensus estimates of $6.86 by $0.15. Anthem had a net margin of 4.22% and a return on equity of 18.45%. The business had revenue of $32.10 billion for the quarter, compared to analysts’ expectations of $32.98 billion. During the same period last year, the business earned $6.48 earnings per share. The business’s quarterly revenue was up 9.0% on a year-over-year basis. As a group, analysts predict that Anthem, Inc. will post 22.44 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 25th. Shareholders of record on Thursday, June 10th will be paid a $1.13 dividend. The ex-dividend date is Wednesday, June 9th. This is an increase from Anthem’s previous quarterly dividend of $0.95. This represents a $4.52 annualized dividend and a yield of 1.17%. Anthem’s payout ratio is currently 23.25%.
A number of analysts recently issued reports on ANTM shares. Truist Securities raised their price objective on shares of Anthem from $425.00 to $450.00 and gave the stock a “buy” rating in a report on Tuesday, April 20th. Royal Bank of Canada raised their target price on Anthem from $350.00 to $399.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 28th. Stephens lifted their price objective on Anthem from $395.00 to $430.00 and gave the stock an “overweight” rating in a report on Wednesday, April 28th. BMO Capital Markets lifted their target price on shares of Anthem from $440.00 to $450.00 and gave the stock an “outperform” rating in a research note on Thursday, April 22nd. Finally, Zacks Investment Research downgraded shares of Anthem from a “hold” rating to a “sell” rating and set a $379.00 price objective for the company. in a report on Thursday, March 25th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $388.00.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Featured Article: Momentum Investing
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.